Icatibant


( Last Updated : March 4, 2014)
Generic Name:
Icatibant
Project Status:
Complete
Therapeutic Area:
Hereditary angioedema
Manufacturer:
Shire Human Genetic Therapies (Canada) Inc.
Call for patient/clinician input open:
Brand Name:
Firazyr
Project Line:
Reimbursement Review
Project Number:
SR0375-000
Call for patient/clinician input closed:
NOC Status at Filing:
Pre NOC

Details


Submission Type:
Initial
Indications:
Angioedema, hereditary
Recommendation Type:
List with clinical criteria and/or conditions
Final Recommendation: